People with no experience throw scientific studies around all the time as if they actually understand wha they’re talking about.
Exactly WHAT IS DIFFICULT about the studies I JUST POSTED AGAIN.........hmmm..........Do you have a Reading comprehension problem..........hmmm
It states CLEARLY.....that in the Study.....40 to 60 % have some immunity or immunity with the virus.............because of past corona viruses......and the body's T Cells remember how to fight it.
Which is why under 50 the death rate is like .001%...........But that doesn't push the FEAR NARRATIVE your side has been pushing from the beginning............I posted the studies from the beginning of this.......and still do...........OH WELL.
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and…
www.sciencedirect.com
Summary
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in ∼70% and 100% of COVID-19 convalescent patients, respectively. CD4+ T cell responses to spike, the main target of most
vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%–27% of the total CD4+ response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8+ T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted. Importantly,
we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2.
www.npr.org
